ACADIA PHARMACEUTICALS INC (ACAD) Class Action Lawsuit (April 2021)
In Litigation3:21cv762 • April 19, 2021
Class Period Start
September 9, 2019
Class Period End
April 4, 2021
PSLRA Deadline
June 21, 2021
Case Allegations
10b5
Statutes of Repose
Sep 9, 2022
Country
United States
Court
Federal Court
Docket History
Jun 8, 2026
Nov 12, 2025
Motion for Summary Judgment (opens in a new tab)
A party has asked the court to decide some or all of the claims without going to trial. The judge will review the motion and determine whether the claims can be decided without a trial.
Mar 11, 2024
Class Certification Granted (opens in a new tab)
The court has determined that a class action is the appropriate method to bring the claims by class members. Usually, when a class is certified, the judge will also affirm an individual or entity to represent the class and finalize a class definition (i.e.: who is represented in the lawsuit).
Aug 21, 2023
Motion for Class Certification (opens in a new tab)
The plaintiffs have asked the court to approve the lawsuit to proceed as a class action on behalf of a group of investors. The judge will decide whether the case meets the requirements for class certification and which investors and claims may be included.
Sep 27, 2022
Motion to Dismiss Denied (opens in a new tab)
The court has denied the defendants' request to dismiss the lawsuit. The case can now move forward to the next stage of litigation.
Feb 15, 2022
Motion to Dismiss (opens in a new tab)
After reviewing the complaint(s) filed by plaintiffs, defendants have filed a motion requesting that the court dismiss some or all of the plaintiffs' claims. In a motion to dismiss, defendants might challenge the validity of plaintiffs' claims or adequacy of plaintiffs' pleadings. Once a motion to dismiss is filed, the judge will make a decision on whether part or all of the case should be dismissed or the case can proceed as alleged.
Dec 10, 2021
First Amended Complaint (opens in a new tab)
A new complaint has been filed on behalf of certain investors in ACADIA PHARMACEUTICALS INC. Amended complaints may contain additional facts, parties, allegations, a change in the class definition, etc.
Nov 16, 2021
Sep 29, 2021
Appointment of Lead Plaintiff (opens in a new tab)
The court has appointed a lead plaintiff to represent the interests of investors in the lawsuit. The lead plaintiff works with the attorneys handling the case, helps oversee the litigation, and represents the interests of the proposed class.
Apr 19, 2021
First Filed Complaint (opens in a new tab)
A securities fraud class action complaint has been filed on behalf of certain investors in ACADIA PHARMACEUTICALS INC.